FREDEX LIMITED

Company number 15047074 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

FREDEX LIMITED - Analysis Report

Company Number: 15047074

Analysis Date: 2025-07-29 14:16 UTC

Financial Health Assessment: FREDEX LIMITED (as of 30 June 2024)


1. Financial Health Score: C

Explanation:
FREDEX LIMITED is a newly incorporated micro-entity with modest financial scale and limited historical data. The company shows signs of early-stage operational activity but exhibits some mild financial stress indicators, particularly in working capital management. The score "C" reflects a company that is currently functioning but requires close monitoring and management attention to improve its financial robustness.


2. Key Vital Signs

Metric Value (£) Interpretation
Share Capital 110 Minimal equity base, typical for a newly formed micro company.
Fixed Assets 6,261 Modest investment in long-term assets; indicates some capital expenditure.
Current Assets 44,960 Represents liquid or near-liquid resources; relatively healthy cash-like assets for operations.
Current Liabilities 49,407 Short-term debts slightly exceed current assets, indicating a working capital deficit.
Net Current Assets -4,447 Negative working capital suggests short-term liquidity pressure ("symptom of distress").
Accruals and Deferred Income 1,495 Obligations recognized but not yet paid; adds to short-term liabilities.
Net Assets / Shareholders Funds 319 Positive but very low equity, indicating limited buffer for absorbing losses.
Employees 3 Small team, consistent with micro-entity status and early business stage.

3. Diagnosis

"Symptoms Analysis":

  • The company is in its infancy (incorporated August 2023), so financial statements cover less than a full operational year, limiting trend analysis.
  • A negative net current assets position (-£4,447) signals a working capital deficiency, meaning the company may face challenges meeting short-term obligations without additional cash inflow or financing. This is akin to a patient showing signs of dehydration—manageable but requiring intervention to restore balance.
  • The positive but minimal net assets (£319) and shareholders funds reflect a very thin equity cushion. This limited capital base restricts the company’s ability to absorb operational shocks or invest in growth without external support.
  • The small fixed asset base and workforce size align with a micro-entity operating at a modest scale.
  • No long-term liabilities or provisions suggest no significant debt burden beyond short-term creditors. This is a positive sign akin to a patient without chronic underlying conditions.
  • The company's exemption from audit under the small companies regime means fewer checks but also less detailed financial oversight.

Overall Financial Condition:
FREDEX LIMITED is operational but currently experiences early-stage financial "symptoms" typical of startup or micro-entities: tight liquidity and minimal equity buffer. This is a common scenario where survival depends on managing cash flow carefully and building financial reserves.


4. Recommendations

To improve financial wellness and avoid potential "financial illness," the company should consider:

  • Improve Working Capital Management:

    • Accelerate collection of receivables and negotiate longer payment terms with suppliers to reduce current liabilities pressure.
    • Monitor cash flow forecasts rigorously to anticipate liquidity needs and avoid shortfalls.
  • Strengthen Equity Base:

    • Consider capital injections from shareholders or external investors to build a stronger equity buffer.
    • Retain profits within the business to grow reserves over time.
  • Control Costs:

    • Keep operating expenses tight, especially with a small team, to avoid eroding limited capital resources.
  • Plan for Growth Prudently:

    • Avoid overcommitting to asset purchases or hiring until cash flow stabilizes.
    • Evaluate financing options such as short-term credit facilities only if cost-effective.
  • Regular Financial Monitoring:

    • Maintain up-to-date financial records and perform monthly reviews of key metrics to catch "symptoms" early.
  • Compliance and Reporting:

    • Ensure timely filing of accounts and confirmation statements to maintain good standing and avoid penalties.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.